QurAlis (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- November 19, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,500,000
Company Info
- Founders
- Kasper Roet
- Company Description
- QurAlis Corporation is a Cambridge (USA) based biotech company focused on developing precision therapeutics for ALS and other neurological diseases.
- Market
- Neurological diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Amgen Business Development, MP Healthcare Venture Management, Viva Biotech